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Abstract
Background: Ovarian folliculogenesis in mammals is a complex process involving interactions
between germ and somatic cells. Carefully orchestrated expression of transcription factors, cell
adhesion molecules and growth factors are required for success. We have identified a germ-cell
specific, basic helix-loop-helix transcription factor, FIGLA (Factor In the GermLine, Alpha) and
demonstrated its involvement in two independent developmental processes: formation of the
primordial follicle and coordinate expression of zona pellucida genes.
Results:  Taking advantage of Figla  null mouse lines, we have used a combined approach of
microarray and Serial Analysis of Gene Expression (SAGE) to identify potential downstream target
genes. Using high stringent cutoffs, we find that FIGLA functions as a key regulatory molecule in
coordinating expression of the NALP family of genes, genes of known oocyte-specific expression
and a set of functionally un-annotated genes. FIGLA also inhibits expression of male germ cell
specific genes that might otherwise disrupt normal oogenesis.
Conclusion: These data implicate FIGLA as a central regulator of oocyte-specific genes that play
roles in folliculogenesis, fertilization and early development.
Background
Primordial germ cells migrate to and colonize the mouse
gonad, completing the process during embryonic day 10.5
(E10.5) to E12.5 [1]. Subsequent phenotypic sexual
dimorphism is defined by the gonad and mice lacking Sry
located on the Y chromosome follow a constitutive female
pathway [2], presumably instructed by a unique set of
genes [3]. Entrance of female germ cells into meiosis at
E13.5 is a defining event mediated by retinoid responsive
genes [4,5]. A second major transition occurs perinatally
when flattened granulosa cells surround individual germ
cells to form primordial follicles [6], forming a reservoir
of eggs available for subsequent fertilization [7]. Germ
cells that fail to interact with the gonadal somatic cells,
either by ectopic location [8] or in the absence of a critical
oocyte-specific transcription factor, FIGLA (previously
known as FIGα)[9], do not survive.
FIGLA (Factor  In the GermLine,  Alpha), a basic helix-
loop-helix transcription factor, was first defined in the
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coordinate regulation of three genes (Zp1,  Zp2,  Zp3)
encoding proteins that form the zona pellucida surround-
ing ovulated eggs [10]. FIGLA transcripts are detected as
early as E13.5 in the embryonic gonad and persist in the
adult ovary [9]. FIGLA protein, however, is not detected
until E19 based on sensitive gel mobility shift assays [11].
Mice lacking FIGLA have normal embryonic gonad devel-
opment, but primordial follicles do not form at birth and
germ cells are lost within days. Female, but not male, mice
are sterile [9]. These data suggested that FIGLA plays criti-
cal roles in female germline and follicle development, but
the full complement of downstream gene targets involved
in these processes and when in development they become
activated have not been defined
Using cDNA microarrays, we have compared the tran-
scriptomes of normal and Figla null ovaries at four devel-
opmental time points (E12.5 to newborn). These results
have been complemented with SAGE (Serial Analysis of
Gene Expression) libraries derived from newborn ovaries
to identify potential direct and indirect gene targets of
FIGLA in female gonad development.
Results
Microarray data analysis
To identify potential downstream gene targets of FIGLA,
total RNA was obtained from normal and Figla  null
gonads isolated from E12.5, E14.5, E17.5 and newborn
female mice. Three independent biological samples
obtained from each embryonic time point and four from
newborn gonads were linearly amplified, labeled with
Cy3 and Cy5 and hybridized to the National Institute of
Aging (NIA) cDNA microarray consists of ~22K features
enriched for transcripts from newborn ovaries, pre- and
peri-implantation embryos [12,13]. After washing, the
average statistically significant intensities for each element
were analyzed with Gene Spring GX software. Features
that varied more than 2-fold (with a coefficient of vari-
ance less than 30%) between normal and Figla  null
gonads were selected for further analysis.
The M (mean log ratio) vs. A (average log2 signal value)
scatter plots reflect the fold change of differentially
expressed genes in Figla null and normal ovaries on the Y
axis relative to their abundance on the X axis (Fig. 1).
Thus, transcripts with low intensity ratios (blue) indicate
genes that are potentially up-regulated by FIGLA and tran-
scripts with high intensity ratios (red) represent genes that
are potentially down-regulated by FIGLA. As expected, no
genes were differentially expressed at E12.5, a point in
development prior to the onset of Figla expression. Only
a few differences were observed at E14.5 and E17.5 with 6
and 4 genes up-regulated ≥ 2-fold (ρ ≥ 0.05) in normal
ovaries and 8 and 1 up-regulated in Figla null ovaries,
respectively (Fig. 1A). In marked contrast, 176 transcripts
were ≥ 2-fold more abundant in normal and 44 were ≥ 2-
fold more abundant in Figla null newborn ovaries (ρ ≤
0.05).
Developmental hierarchical cluster analysis of FIGLA 
regulated genes
The average intensities of hybridization of the 176 genes
that were less abundant (i.e. potentially up-regulated, Fig.
2A) and the 44 genes that were more abundant (i.e.,
potentially down-regulated, Fig. 2B) in Figla null newborn
ovaries were compared by hierarchical cluster analysis.
Almost all the 176 potentially up-regulated genes showed
similar expression pattern wherein the expression of these
genes commenced only at newborn stage of the ovary
development. As expected, both Zp2 and Zp3, previously
described direct downstream targets of FIGLA, were up-
Differential gene expression in normal and Figla null ovaries Figure 1
Differential gene expression in normal and Figla null 
ovaries. A. Embryonic ovarian transcriptomes of normal and 
Figla null mice at embryonic days E12.5, E14.5, E17.5 and 
newborn. For elements in the NIA microarray, the mean 
intensity ratio log2 null (red) over normal (blue) on X axis is 
plotted against the average intensity ratio log2 null and nor-
mal on Y axis. Data represent mean of 3–4 independent bio-
logical samples with Cy3 and Cy5 dye reversals and spiked 
Ambion RNA controls. B. Same as (A) except restricted to 
expression profiles of 203 newborn genes regulated by 
FIGLA (≥ 2 fold, ρ ≤ 0.05, after analysis of variance).
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regulated in the normal newborn ovaries, although they
were not closely clustered to each other. The four genes
[NIA:551381, H330A03, H3134D03, H3058H02] that
were first up-regulated E17.5 and persisted in the new-
born also did not cluster together (dots, Fig. 2A). The cor-
responding positions of the genes which were further
characterized by qRT-PCR and in situ hybridizations are
marked by asterisks and labeled. The 44 genes which were
potentially down regulated by FIGLA (i.e., more abundant
in Figla null ovaries) all had similar expression patterns
with the major change in expression occurring in the new-
born ovary (Fig. 2B).
Of these, 165 of the potentially up-regulated and 38 of the
potentially down-regulated transcripts were judged to dif-
fer with statistical significance after analysis of variance
(ANOVA). There was no overlap of regulated genes (≥ 2-
fold, ρ ≤ 0.05) among the various time points except for 2
genes [NIA:551381, NIA:H330A03] up-regulated at E17.5
that were also up-regulated in the newborn ovary (Fig.
1B). Genes that were potentially up- and down-regulated
are provided (see Additional files 1 and 2). Using gene
ontology software PANTHER [14], the 203 genes that
were differentially-regulated in the newborn were ana-
lyzed based on their molecular function (Table 1). Of the
165 up-regulated genes, 25% were grouped in unknown
molecular function category, 13% were nucleic acid bind-
ing proteins, 7% were transcription factors and 6% were
genes with transferase activity. Of the 38 down-regulated
genes, 23% were transcription factors, and 20% encoded
proteins with nucleic acid binding functions. Two of these
genes, Taf7l and Tia1, are normally expressed in the testes.
Genes with unknown molecular function and transferase
activity were comparable (25% and 7%, respectively) to
the up-regulated genes.
Ovarian genes affected by Figla expression
Thirteen genes that were ≥ 2-fold more highly expressed in
normal than Figla null newborn ovaries were chosen for
more detailed analysis. Three were members of the Nalp
gene family that have oocyte-specific expression [15]; five
were functionally annotated genes with oocyte-specific
expression; and five were functionally un-annotated. Two
additional members of the Nalp family (Nalp4a, Nalp14)
that were up-regulated by FIGLA, albeit to a lesser extent,
were included in the analysis and two of the selected genes
(Oas1d, [Genbank:BC052883]) missed the statistical cut-
off because of single (out of eight) outlying data points
(shaded backgrounds in Figs 3, 4, 5). Primers specific for
each gene were designed (see Additional file 3) and the
presence and absence of specific transcripts in newborn
normal and Figla null ovaries were confirmed in 14 of the
15 by qRT-PCR (all but Nalp4a).
Total RNA was isolated from 9 normal newborn organs
and assayed for gene expression which was normalized to
HPRT and standardized to 100% in the ovary (Fig. 3A). As
previously reported, all five Nalp genes were expressed in
the ovary with low levels of transcripts (< 5% of ovarian
expression) observed in the uterus for Nalp14 and in the
liver for Nalp4a of newborn mice. The developmental
profiles of transcript abundance from E12.5 to newborn
were consistent with FIGLA regulating expression of
Nalp4b, Nalp5, Nalp4f and Nalp14. No expression was
detected in E12.5, E14.5, E17.5 or newborn gonads iso-
lated from Figla null mice, but all five genes were
expressed in normal newborn ovaries. However, the
absence of FIGLA did not preclude expression of Nalp4a
in newborn ovaries, although expression was ~60% of
normal. Although the members of the Nalp gene family
share structural motifs and are co-expressed in oocytes,
they are not functionally redundant and the inactivation
of one (Nalp5) is sufficient to arrest pre-implantation
development [16].
Among the other annotated genes, each was preferentially
expressed in the ovary with only low levels (< 5% of ovar-
ian expression) of Oas1d, Serpinb6C and Arhgap20 tran-
scripts in other tissues in newborn mice (Fig. 4A).
Expression of Pdzk1 and Elavl2 was less tightly controlled
with transcripts detected in kidney (~25% of ovarian
Hierarchical clustering of transcripts Figure 2
Hierarchical clustering of transcripts. Developmental 
hierarchical clustering of newborn transcripts potentially up- 
(A) or down-regulated (B) by FIGLA. Individual genes are 
represented by horizontal bar. Each lane represents an inde-
pendently obtained biological sample (three for E12.5, E14.5 
and E17.5; four for newborn) with Cy3 and Cy5 dye revers-
als indicated at the bottom. Blue represents greater abun-
dance in the presence of FIGLA and red indicates less. Four 
genes [NIA:551381, NIA:H330A03, NIA:H3134D03, 
NIA:H3058H02] up-regulated at E17.5 and newborn are indi-
cated with dots to the left. Genes encoding transcripts char-
acterized in greater detail are indicated by an asterisk and are 
labeled to the right. Both Zp2 and Zp3 were identified by the 
screen, but not characterized further.
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expression) and brain (~40%), respectively. Each of these
five genes was first detected in the newborn ovary where
their expression was dependent on FIGLA (Fig. 4B). These
observations are consistent with each gene being a direct
downstream target of FIGLA, but transcripts of each are
detected in adult tissues, suggesting that other transcrip-
tion factors play a role in developmental and organ spe-
cific expression. Oas1d encodes an oocyte-specific dsRNA,
2'5'-oligoadenylate synthetase that is ~60% identical to
OAS1A that has been implicated in the interferon defense
response against viral infections. Genetically altered mice,
lacking OAS1D, are fertile, but have reduced fecundity
associated with lowered ovulatory capacity and defects in
early embryonic development [17]. Mice lacking PDZK1,
implicated in controlling ion transport and cholesterol
metabolism [18], had normal fertility and produced off-
spring with the expected Mendelian inheritance of the
Pdzk1 null allele [19].
Tissue and developmental expression of unannotated 
genes
Five additional genes that were more abundant in normal
than in Figla null newborn ovaries and functionally un-
annotated were also selected for further evaluation (Fig.
Table 1: Differentially regulated genes
Gene ontology Up-regulated genes Down-regulated genes
Microarray SAGE Microarray SAGE
Nucleic acid binding 
proteins and transcription 
factors
Pou5f1, E2f5, Stat3, Lcp1, 
Zfp313, Og2X, Rex, Helic1, 
Cpeb3, Elav2, Cpeb1, 
Dhx40Top3b, Ccrn41, 
E430034L04b, 5830484A20
Pou5f1, Sp3, Dtx2, Peg3, 
Tcf21, Eef1a1, Rps2, Hdac2
Phtf1, Taf7la, Mrg1, Ncam2, 
Tia1, 1110031M08
Mxd3, Pbx3, MkI1, Sox17, 
Jarid1c, Sp8, Mjd, Mkrn1, 
FhI4, Sdpr, Miz1, BC029103, 
Papolb, Rnaseh2a, Sox17, 
Tdrd6, Sf3a1, 5, Tnp2, 
Mgmt, Hils1, AV34037
Receptors Kit, Grid2, Drd3, Trpm7 Lum, Obrgrp Gabra2, Pvrl3, Tcp10b, 
Plxnb3, Mass1
Extracellular matrix 
proteins
Zp2, Zp3, Col9a3 Zp2, Leprel2, Col1a1, 
Mfap2,
Cell adhesion molecules Pcdhga12
Chaperones Grpel2, Tor3a Hspa8, Vbp1 ClgnDnajb1, CPN60, Osp94, 
Dnajb3, Hsbp9
Cytoskeletonal proteins Kif14, Rdx, Lmo7, Lcp1, 
AI427122, 2900002G04
Flna Kif2b, Dncl2b, Actl7a, Tuba3, 
Tekt1, Fscn3, Tuba5, Rsn, 
Dnahc8, Tns
Defense and immunity And, H2-Bf, Pvrl3
Hydrolases Thedc1, Helic1, Exo1, 
D7Ertd445e, 2610020H15
Rnaseh2a, Ephx2, Asrgl1, 
Dnahc8, Dpysl3, AV340375,
Oxido-reductases Aof1, Aass Paox, Prdx1, Akr1a4 Ldhal6b, Sdh1, Ldhc, 
Cyp11a1, Txndc2, Gpd2, 
Sqrdl, prdx6-rs1, Cyp17a1, 
Akr1c19, Mcsp, AL024210
Synthases Oas1c, Slc27a2 Oas1h
Isomerases Top3b Pgam2, Ppil1
Kinases Rock1, Ak4 Stk33, Dyrk3, Plxnb3, 
Cdc2l6,
Ligases Herc3, Slc27a2, Rnf35, 
2610020H15
Herc4, Fbox36, Rnf133, 
Acsl1, Miz1, Glul, Rnf139,, 
Senp7, 630025C22
Proteases Ctrc, Prep And, Tpp2, Ctsd, 3, Asrgl1, 
Klk6, Adam3, 1700074P1
Transferases Chst10, Fdft1, Bcat1, 
Nmna3, Ipmk, 
Ak44930403J22, 
4930487N19
Ogt, Siat9 Ilvbl, Got2 Tcp10b, Sia5, B4galt1, 
Mgmt, Sas
Cell junction proteins Pard3
Carrier proteins Osbpl8 Scamp5
Membrane traffic proteins Beta-NAP Stxbp1, Clta Stx6
Ion channels Trpm7, Grid2 Prdx1 Gabra2, Kcne3, Kcnk4
Select regulatory molecules Chn1, Argap20, Top3b, 
Serpinb6C
Rraga Oaz3, Akap3, Ppp1r3a, 
Dusp18, 4933414G08
aTestis-associated genes are in bold
bGenbank accession numbersBMC Developmental Biology 2007, 7:67 http://www.biomedcentral.com/1471-213X/7/67
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5). Three [E330009P21Rik, E3300017A01Rik, Gen-
bank:BC052883] were detected only in the ovary by qRT-
PCR and the remaining two [C330003B14Rik,
E330034G19Rik] had only low levels of expression in
other tissues. All five genes had similar developmental
profiles as the aforementioned genes with little expression
prior to birth and virtual absence of expression in Figla
null ovaries.
In situ hybridizations were performed using the digoxi-
genin-labeled oligonucleotide probes designed specifi-
cally for transcripts of each gene (Additional file 4). All the
functionally unknown genes showed predominant
expression in oocytes (Fig. 6) with only background stain-
ing surrounding ovarian tissue. Although some binding
was observed with sense probes for [E330017A01Rik,
C330003B14Rik and Genbank:BC052883](Fig. 6D, F, J),
it was minor compared to the strong signals observed with
anti-sense probes (Fig. 6C, E, F).
SAGE analysis of normal and Figla null newborn ovaries
The developmental microarray analysis suggested that sig-
nificant differences in potential FIGLA gene targets were
not observed prior to birth. Therefore, to complement
these data and avoid the bias introduced by pre-selection
of elements on the microarrays, a SAGE analysis was
undertaken to provide identity and relative abundance of
individual transcripts. Total RNA was isolated from new-
born ovaries and used to construct a normal and a Figla
null SAGE library in which transcripts were identified by a
10 nt tag and their relative abundance by the number of
tags detected. The 79,095 quality tags sequenced from the
normal library and the 77,851 from the null library repre-
sented 23,595 and 32,123 different transcripts, respec-
Expression of known genes Figure 4
Expression of known genes. Tissue-specific and develop-
mental expression of five known genes potentially up-regu-
lated by FIGLA. A. qRT-PCR of total RNA isolated from 
somatic and reproductive tract tissues normalized to HPRT 
and plotted relative to 100% expression in ovary. B. qRT-
PCR of total ovarian RNA isolated from normal and Figla null 
mice at E12.5, E14.5, E17.5 and newborn and plotted relative 
to HPRT. Data is the average (± s.e.m.) of two independently 
isolated biological samples, analyzed in triplicate at each 
developmental time point. Oas1d (shaded) missed the statisti-
cal cutoff because of a single (out of eight) outlying datum 
point.
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Expression of NALP genes Figure 3
Expression of NALP genes. Tissue-specific and develop-
mental expression of NALP genes potentially up-regulated by 
FIGLA. A. qRT-PCR of total RNA isolated from somatic and 
reproductive tract tissues normalized to HPRT and plotted 
relative to 100% expression in ovary. B. qRT-PCR of total 
ovarian RNA isolated from normal and Figla null mice at 
E12.5, E14.5, E17.5 and newborn and plotted relative to 
HPRT. Data is the average of two independently isolated bio-
logical samples, analyzed in triplicate at each developmental 
time point. Nalp4a (ita) and Nalp14 (iota)(shaded) were pre-
viously identified as ovary-specific and were not represented 
in microarray or SAGE data.
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tively. 15,838 tags were unique to the normal library;
24,366 were unique to the null library and 7,757 were
present in both. To avoid sequence-error artifacts, only
tags that were observed at least twice in the normal
(7,715) and Figla  null (9,477) SAGE libraries were
included in subsequent analyses (Fig. 7A).
Using the Audic and Claverie algorithm that incorporates
Bayesian and false alarm analyses [20], 977 genes more
highly expressed in the normal library and 1308 genes
more highly expressed in the Figla null library were iden-
tified (Fig. 7B). The data also were analyzed with other sta-
tistical tests commonly used for SAGE [21] and Fisher's
exact test provided similar results (> 90% overlap) with
810 genes more highly expressed in normal and 1318
more highly expressed in null ovaries. However, only
Pou5f1 (Oct4) and Zp2 were observed as up-regulated in
both newborn microarrays and SAGE libraries and no
commonly down regulated genes were observed among
those identified by SAGE and by microarray analyses.
Although the microarray and SAGE screens were selected
to complement one another in identifying potential
downstream targets of FIGLA, the lack of overlap in targets
was unanticipated. The data from the newborn normal
and Figla null microarray data were reexamined by False
Discovery Analysis [22]. Of 2,233 identified features (FDR
threshold of 5%) from the microarray data, 1,550 had sin-
gle unigene annotations [23], 202 mapped to multiple
clusters and 248 were not mapped. Of the annotated
genes, 768 were up-regulated (see Additional file 5) and
782 were down-regulated (see Additional file 6). Eleven
genes (marked in Additional files 5, 6), including Pou5fl
In situ hybridization Figure 6
In situ hybridization. In situ hybridization of the five func-
tionally un-annotated genes potentially up-regulated by 
FIGLA. Paraformaldehyde fixed and paraffin embedded adult 
ovarian section were hybridized with digoxigenin (DIG) 
labeled antisense (A, C, E, G, I) or sense (B, D, F, H, J) syn-
thetic oligonuclotides probes specific to [E330009P21Rik] (A, 
B), [E330017A01Rik] (C, D), [C330003B14Rik] (E, F), 
[E330034G19Rik] (G, H) and [Genbank:BC052883] (I, J) 
cDNAs.
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Expression of un-annotated genes Figure 5
Expression of un-annotated genes. Tissue-specific and 
developmental expression of five functionally un-annotated 
genes potentially up-regulated by FIGLA. A. qRT-PCR of 
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expression in ovary. B. qRT-PCR of total ovarian RNA iso-
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and newborn and plotted relative to HPRT. Data is the aver-
age (± s.e.m.) of two independently isolated biological sam-
ples, analyzed in triplicate at each developmental time point. 
[Genbank:BC052883] (shaded) missed the statistical cutoff 
because of a single (out of eight) outlying datum point.
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and Zp2 from our initial analysis, were also present in our
SAGE analysis. Eight were up-regulated (Pou5f1,  Zp2,
Ivns1abp,  Vbp1,  Padi6,  Rbpms2, Genbank:EG626058,
6430591E23Rik) and three were down-regulated (Sp3,
Hdac2, Ogt) in newborn normal ovaries. Because alterna-
tive statistical analyses [24-26] may be useful for the com-
parison of these data sets, we have made the original
microarray and SAGE data available at Gene Expression
Omnibus [27] under accession GSE5558 and GSE5802,
respectively.
Of the genes identified in the SAGE screen, 64 (see Addi-
tional file 7) of the potentially up-regulated genes had ≥
10 tags in normal and none in the null and 312 (see Addi-
tional file 8) of the potentially down-regulated genes had
≥ 10 tags in the null and none in normal ovaries. These
376 tags were reliably mapped to genes using the NCBI
SAGE database [28] and ontology of 112 was determined
by PANTHER (Table 1). The greatest percentage (26%) of
genes were nucleic-acid binding proteins (including tran-
scription factors) followed by oxidoreductases (13%),
cytoskeletonal proteins (10%) and ligases (8%). Ten of
the down-regulated genes (Tnp2, Hils1, Clgn [Calmegin],
Tekt1,  Fscn3,  Dnahc8,  Ldh3,  Adam3 [Cyritestin],  Oaz3,
Akap3), scattered among the categories, have sperm-asso-
ciated patterns of expression (Table 1).
Expression of eight up-regulated genes from the SAGE 
analysis
Eight transcripts for which there were ≥ 10 tags in the nor-
mal and 0 tags in the Figla null newborn SAGE libraries
(Pou5f1,  Dppa3,  Oas1h,  Padi6, [Genbank:AK087784,
2410146L05Rik, Genbank:BG074389, Gen-
bank:AK139812]) were analyzed further. Transcripts for
each were detected by semi-quantitative RT-PCR in nor-
mal, but not Figla null newborn ovaries. Total RNA from
11 tissues was analyzed and transcripts for each gene were
detected only in ovarian tissue, with the exception of
Pou5f1, which was also present in testis (Fig. 8A).
Expression of FIGLA targets Figure 8
Expression of FIGLA targets. Tissue-specific and devel-
opmental expression of eight genes potentially up-regulated 
by FIGLA in SAGE analysis. SAGE tags for each gene were 
absent in the Figla null newborn library and present ≥ 10 in 
the normal newborn library. A. Semi-quantitative RT-PCR of 
total RNA isolated from somatic and reproductive tract tis-
sues with primers specific for each of the eight genes. B. 
qRT-PCR of total ovarian RNA isolated from normal and 
Figla null mice at E12.5, E13.5, E15.5, E17.5, E19.5, newborn 
(NB), 2dpp and 7dpp and plotted relative to HPRT. Data is 
the average (± s.e.m.) of 2–6 independently isolated biologi-
cal samples, analyzed in triplicate at each developmental time 
point.
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which were down-regulated (SP3, HDAC2, OGT) in new-
born normal ovaries.
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Pou5f1  (Oct4) is expressed in pluripotent cells during
mouse development before becoming restricted to germ
cells [29] and regulates a significant number of down-
stream target genes by itself and in tandem with other
transcription factors [30]. The complex pattern of
POU5F1 transcripts in normal and Figla null mice (Fig
8B) indicates participation of other transcription factors
in controlling its expression. Expression of the other seven
genes was not detected in Figla null mice (except for a very
modest accumulation of [Genbank:BG084789] at E15.5)
and was first observed in normal ovaries at E15.5 (Dppa3,
[Genbank:AK139812] or E19.5 (Oash1,  Padi6, [Gen-
bank:AK087784, 2410146L05Rik, Gen-
bank:AK139812])(Fig. 8B).
Dppa3 (Stella), originally implicated in germ cell lineage
specification [31], is a maternal effect gene required for
pre-implantation development [32,33]. Oas1h encodes a
2'5'-oligoadenylate synthetase and clusters with Oas1d
(detected by microarray analysis) along with 6 other
closely related synthetases on mouse Chr5:119,938,130-
120,073,460 [34]. Padi6 (Padi5) is one of 4 similar genes
(Padi1–4) clustered on mouse Chr4:139,787,689-
139,623,878 that encodes a peptidylarginine deiminase
which converts arginine residues into citrulline [35]. It is
expressed during oogenesis where it is associate with cyto-
plasmic sheets and the protein persists in the early embryo
up to the blastocyst stage [36].
Each of the remaining four SAGE tags matched either
cDNA or spliced EST that was expressed in ovarian tissue
and/or the early mouse embryo. [Genbank:AK087784] is
a full-length cDNA from a 2 days pregnant adult female
ovary [E330020D12Rik] that maps to mouse
Chr1:153,290,975-153,292,514 and [2410146L05Rik] is
a female germline specific cDNA that encodes a hypothet-
ical 166 amino acid protein mapping to mouse
Chr9:78,577,285-78,578,468. [Genbank:BG074389], a
532 bp spliced EST (Chr11:7,077,950-7,079,635), is part
of the NIA15K cDNA clone set and was up-regulated in
the microarray screen, albeit not to a statistically signifi-
cant extent. [Genbank:AK139812] was reliably matched
by a SAGE tag that also matched two other sequences, nei-
ther of which was ovary specific. [Genbank:AK139812]
corresponds to a full-length cDNA [B020018122Rik]
obtained from a 2-cell embryonic library and maps as a
spliced EST on mouse Chr12:107,907,672-107,914,726.
Discussion
During ovarian development, oocytes accumulate mater-
nal products necessary for successful folliculogenesis, fer-
tilization and pre-implantation development. FIGLA is an
oocyte-specific, basic helix-loop-helix transcription factor
required for perinatal formation of primordial follicles
and the establishment of the extracellular zona pellucida
matrix that surrounds eggs to mediate fertilization and an
embryonic block to polyspermy. Transcripts encoding
FIGLA are first detected at E13.5 in female gonads and per-
sist in adult ovaries [9,10]. The involvement of FIGLA in
two, independent, oocyte-specific genetic pathways and
its persistence during critical periods of ovarian develop-
ment suggest that FIGLA may regulate other genes critical
for successful gonadogenesis and development. Two com-
plementary approaches using spotted-glass microarrays
and Serial Analysis of Gene Expression (SAGE) have been
combined to identify additional potential downstream
targets of FIGLA.
Taking advantage of Figla null mice and the NIA ~22K
microarray that contains elements enriched for expression
in oocyte and early development [12,13], ovarian gene
expression was profiled at four embryonic time points
from E12.5 to newborn. No statistically significant differ-
ences (≥ 2X, ρ ≤ 0.05) in transcript abundance between
normal and Figla null mice was observed at E12.5 and
E14.5 and only two transcripts differed at E17.5. How-
ever, in newborn ovaries, 165 genes were up-regulated
(i.e., less abundant in Figla null) and 38 were down-regu-
lated (i.e., more abundant in Figla null). This develop-
mental time point is just after FIGLA protein is detected in
a sensitive gel mobility shift assay [11] and coincident
with the first phenotypic manifestation of Figla null mice
[9]. Thus, although Figla transcripts are detected as early as
E13.5, the major affect on ovarian gene expression occurs
perinatally.
Microarrays are limited by the elements spotted on glass
during their fabrication. Therefore, to broaden the search
for potential direct or indirect downstream gene targets,
SAGE libraries were constructed from poly(A)+ RNA iso-
lated from newborn normal and Figla null ovaries. A 10
base tag immediately adjacent to the 3' most Sau3A1
restriction enzyme cleavage site was used to identify 7,715
transcripts in normal and 9,455 transcripts in Figla null
mice. Of the genes encoding these transcripts, 977 were
up-regulated and 1,308 were down-regulated when ana-
lyzed with statistics that incorporate Bayesian and false
alarm analyses [20]. Unigene designations were available
for 838 of the up-regulated and 648 of the down-regu-
lated genes and 31% (334 up-regulated; 131 down-regu-
lated) were represented among the elements on the NIA
microarray. Initially only two (Pou5f1 and Zp2) were iden-
tified as up-regulated on both platforms. However, rean-
alysis of the newborn microarray data with an FDR
threshold of 5% [37] identified 11 genes in common,
eight of which were up-regulated (Pou5f1, Zp2, Ivns1abp,
Vbp1,  Padi6,  Rbpms2, Genbank:EG626058,
6430591E23Rik) and three of which were down-regulated
(Sp3, Hdac2, Ogt) in newborn normal ovaries. A similar
lack of concordance among different platforms analyzingBMC Developmental Biology 2007, 7:67 http://www.biomedcentral.com/1471-213X/7/67
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the same biological samples, particularly for genes with
low abundance, has been observed previously [38-41].
'Guilt by association' has been invoked to identify genetic
hierarchies, members of which are co-regulated by specific
transcription factors (for review, see [42]). In examining
the ontology of the differentially regulated genes detected
by microarray and SAGE analysis, nucleic acid binding
proteins and transcription factors formed the largest
group. One gene, Pou5f1 (Oct4) in this grouping was up-
regulated by FIGLA on both platforms and is initially
present in primordial oogonia prior to down-regulation
as female germ cells enter the prophase of meiosis I
(~13.5E). Perinatally, Pou5f1  transcripts and POU5F1
protein once again become abundant in growing oocytes
[43] and persist in the early embryo prior to zygotic
expression which begins in 4-cell embryos. Although ini-
tially present in all blastomeres, Pou5f1  transcripts
becomes restricted to the inner cell mass, the epiblast and
finally primordial germ cells by E8.5 [44]. The expression
of Pou5f1 is regulated by a TATA-less promoter with distal
and proximal enhancers implicated in regulating tran-
script levels during embryogenesis [45]. However, the
molecular control of Pou5f1  expression during game-
togenesis has not been determined. A canonical E-box
(CANNTG) is present -261 bp upstream of the Pou5f1
transcription start site and represents a well-defined bind-
ing sites for basic helix-loop-helix transcription factors
[46]. FIGLA protein is first detected at E19 [11] just prior
to the post-natal up-regulation of Pou5f1 [43] and in both
microarray and SAGE analyses, Pou5f1  expression is
down-regulated in Figla null mice. These data are consist-
ent with FIGLA acting as a regulator of Pou5f1 expression
in the female germline, although other factors must play
a role as well.
Structural proteins, including those involved with extra-
cellular matrices and intracellular cytoskeleton were also
well represented in the gene ontology analysis and one,
Zp2, was up-regulated by FIGLA on both platforms
(microarray and SAGE). Zp2 encodes a major component
of the mouse zona pellucida that surrounds growing
oocytes, ovulated eggs and pre-implantation embryos
[47]. Mice lacking ZP2 initially form a thin zona matrix
composed of ZP1 and ZP3 that does not persist and no
zona pellucida is observed in ovulated eggs which renders
female mice sterile [48]. FIGLA was initially defined as
transcription activating activity that bound to a conserved
E-box, within the first 200 bp of Zp1, Zp2 and Zp3 pro-
moters and was subsequently isolated by expression clon-
ing [10,49]. ZP2 transcripts can be detected as early as
E19, although the zona matrix does not form until
oocytes begin to grow after birth; no ZP2 transcripts are
detected in Figla  null mice [9]. Thus, Zp2  expression
appears to reflect direct targeting of FIGLA during the
onset of oogenesis.
All twenty-three of the genes selected from the microarray
and SAGE screens were preferentially expressed in new-
born ovarian tissue, although significant levels of Pdzk1
and Elavl2 transcripts were detected in kidney and brain,
respectively. There was considerable variation in levels of
expression in normal newborn ovaries, ranging from 14–
400% of HPRT levels which may indicate the importance
of additional co-factors in regulating gene expression,
although differing efficiencies of PCR amplification may
affect these comparisons. All genes (except Nalp4a) were
virtually absent in newborn Figla null ovaries. Those genes
expressed uniquely in oocytes, may be of particular
importance in ovarian gonadogenesis.
Although well appreciated in simple model organisms,
only in recent years have maternal effect genes have
become well documented in mice. The protein products
of these genes accumulate during oocyte growth and are
required for successful embryogenesis. While it remains
controversial whether such maternal products play a role
in establishing embryonic polarity [50,51], there is
increasingly ample molecular evidence that maternal
effect genes are critical in pre- [16,32,33,52-59] and post-
implantation [57,60-63] development. Mater  (Maternal
antigen  That  Embryos  Require) was one of the earliest
maternal effect genes molecularly characterized in mice.
Mice lacking this 125 kDa cytoplasmic protein have nor-
mal gonadogenesis and ovulate eggs that can be fertilized,
but do not progress beyond the two-cell stage [16]. Mater
(Nalp5) is a member of the Nalp family and genetic stud-
ies are underway to determine if other members regulated
by FIGLA (Nalp4b, Nalp4f, Nalp14) affect pre-implanta-
tion in mice. A second maternal effect gene Dppa3 (Stella),
also required for pre-implantation development [32,33],
was detected by the SAGE analysis and there may be oth-
ers as well.
Of the 350 genes that were significantly less abundant in
normal ovaries (see Additional files 2 and 6), 30 were tes-
tis-associated and 12 were classified by the Panther gene
ontology software (Table 1). Two were transcription fac-
tors, preferentially expressed in the testis, Taf7l and Phtf1.
TAF7L is a TATA box binding protein involved in differen-
tiation of spermatogonia to spermatocytes [64] and
PHTF1 is a putative homeodomain transcription factor
with male germ cell specific expression that binds femi-
nizing factor FEM1B [65,66]. Another two, Tnp2  and
Hils1, encode transition protein 2 and a spermatid-spe-
cific linker histone H1-like proteins, respectively, which
are involved with chromatin remodeling during sperma-
togenesis [67,68]. The remaining 8 genes (Clgn
[Calmegin], Tekt1, Fscn3, Dnahc8, Ldhc, Adam3 [Cyritestin],BMC Developmental Biology 2007, 7:67 http://www.biomedcentral.com/1471-213X/7/67
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Oaz3, Akap3) have well characterized functions in sperma-
togenesis [69-76]. Thus, FIGLA appears to play a role in
preventing expression of male germ cell associated genes
during oogenesis. If true, additional co-factors must inter-
act with FIGLA in determining its affect on downstream
gene targets.
Conclusion
Taken together, these data indicate that FIGLA, an oocyte-
specific, basic helix-loop-helix transcription factor, plays a
pivotal role in modulating multiple genetic hierarchies
involved in folliculogenesis, fertilization and pre-implan-
tation development. Although transcripts accumulate ear-
lier in embryogenesis, FIGLA protein is first detected ~E19
and affects female perinatal gonadogenesis. While some
of the effects on expression may be as direct regulator of
downstream target genes, others may be indirect through
the activation (or suppression) of other transcription reg-
ulator(s). In addition to involvement in the activation of
gene expression, it seems likely that FIGLA will also down-
regulate genes, the expression of which would be inappro-
priate during post-natal oogenesis. The further characteri-
zation of the genes that are differentially regulated by
FIGLA should prove useful in defining developmental
pathways that affect the postnatal female germ cell. These
targets represent not only genes that affect folliculogenesis
and fertilization, but also maternal effect genes required
for successful completion of early mouse development.
Methods
Experimental animals and tissue collection
CF1 mice were obtained commercially and Figla
homozygous null mice [9] were identified by genotyping
tail DNA using three primers (see Additional file 9) in a
PCR reaction (95°C 5 min, 94°C 30 sec, 60°C 30 sec,
72°C 30 sec for 28 cycles). RNA was extracted from
gonads isolated at embryonic day 12.5 (E12.5), E13.5,
E14.5, E15.5, E17.5, E19.5, newborn (NB), 2 days post-
partum (2dpp) and 7dpp females; all other tissues were
obtained from newborn mice. All experiments were con-
ducted in compliance with the guidelines of the Animal
Care and Use Committee of the National Institutes of
Health under a Division of Intramural Research, NIDDK
approved animal study protocol.
RNA extraction and labeling
RNA was extracted from tissue using Absolutely RNA RT
PCR Miniprep Kit (Stratagene, La Jolla, CA) and its integ-
rity was determined with RNA 6000 Nano Lab-on-Chip
(Agilent Technologies, Waldbronn, Germany). For
hybridization to microarrays, 50 µg of total RNA (20 ova-
ries) was linearly amplified with the Aminoallyl RNA
Amplification and Labeling System (NuGen Technolo-
gies, San Carlos, CA) and labeled with ester-linked Cy3
and Cy5 dyes (Amersham Biosciences, Piscataway, NJ).
Microarray hybridization
Labeled cDNA probes were hybridized to NIA cDNA
microarrays on glass slides containing 20,996 features
[12,13] according to Vanderbilt Microarray Shared
Resources protocols [77]. In brief, arrays were washed
(0.2% SDS) at RT and incubated in a pre-hybridization
solution (5 × SSC, 0.1% SDS, 1% BSA) at 55°C for 45 min
[78]. After 5 rinses in Milli Q water and 1 in iso-propanol,
arrays were air dried and overlaid with coverslips. Utiliz-
ing a Maui Hyb Station (BioMicro Systems, Salt Lake City,
UT), the arrays were hybridized (25% formamide, 5 ×
SSC, 0.1% SDS, 1 µg poly(A)+ RNA) at 42°C for 16 h and
then washed (5 min, 55°C) sequentially with 2 × SSC, 1 ×
SSC and 0.1 × SSC, each with 0.1% SDS After drying by
centrifugation (20 × g), the arrays were scanned using the
Axon 4000 B (Axon Instruments, Union City, CA).
Microarray data analysis
Hybridizations were performed in triplicate (E12.5,
E14.5, E17.5) or quadruplicate (newborn) with dye-
swapped pairs of cDNA. The raw data were analyzed with
GeneSpring GX 7.2 (Agilent Technologies, Waldbronn,
Germany) to remove data that did not meet the following
criteria: 1) Cy5 signal to background intensity ratio less
than 1.5; 2) Cy3 signal to background intensity ratio less
than 1.5; 3) Cy5 signal less than 200; and 4) Cy3 signal
less than 200. Data were then normalized by the LOWESS
sub-grid method and features with a coefficient of vari-
ance of less than 30% (across replicate arrays) and ≥ 2-
fold changes between normal and Figla null gonads were
identified. Analysis of Variance (ANOVA) was performed
on the set of genes identified in newborn ovaries. Hierar-
chical clustering of transcripts during development was
determined by GeneSpring GX 7.2.
Alternatively, all eight replicates of newborn ovaries were
used in a one-sample Student's t-test to determine
whether the mean normalized expression value for each
element was statistically different from 1. False Discovery
Rate [37] at a threshold of 5% was used as a multiple test-
ing correction to decrease the number of false positives.
SAGE library construction
Total RNA (~50 µg) was obtained from newborn normal
and Figla null ovaries with an RNeasy mini kit (Qiagen,
Valencia, CA). The presence of MSY2 and the absence of
ZP2 transcripts was assayed by one-step qRT-PCR accord-
ing to the manufacturer's protocol (Qiagen, Valencia, CA)
using oligonucleotide primers (see Additional file 3) to
confirm the identity of Figla null ovaries. Poly(A)+ RNA
was isolated with oligo d(T)-conjugated magnetic beads
(Dynal-Invitrogen, Carlsbad, CA) and 5 µg was used to
construct libraries using a modification [79] of the origi-
nal SAGE protocol [80]. The final concatenated ditags
were cloned into Bluescript pKS (Stratagene, La Jolla, CA)BMC Developmental Biology 2007, 7:67 http://www.biomedcentral.com/1471-213X/7/67
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using the BamHI site for blue-white screening. Plating,
picking, DNA preparation and sequencing were per-
formed at the NIH Intramural Sequencing Center (NISC).
Low quality sequence data were eliminated by Phred anal-
ysis.
eSAGE [81] was used to extract tags and remove duplicate
ditags from the raw sequencing data. 79,095 tags from the
normal were compared to 77,851 tags from the Figla null
libraries to determine statistically significant differences
either by the Audic and Claverie test [20] using eSAGE
[82] or Fisher's exact test [83] using IDEG6 [21]. Tags with
ρ ≤ 0.05 were extracted from both lists and further analysis
was performed on tags present at least 10 times in normal
and absent from Figla null ovaries. These lists of tags were
then mapped to Unigene clusters using reliable mapping
from NCBI Unigne build #138. A group of 13 genes from
the microarray data and 8 from the SAGE analysis that
were up-regulated in normal newborn ovaries were
selected for more detailed analysis based on their expres-
sion profile in the SOURCE data base at the Genetics
Department at Stanford University [23].
Analysis of gene expression
Transcript abundance was determined by quantitative
real-time polymerase chain reaction (qRT-PCR) on an ABI
7700 HT Sequence Detection System (Applied Biosys-
tems, Foster City, CA) using QuantiTect SyBR green PCR
kit (Qiagen, Valencia, CA) and primers (see Additional
file 3) designed by Primer Express 2.0 (Applied Biosys-
tems, Foster City, CA). Independently obtained biological
samples (2–6), analyzed in triplicate were normalized to
HPRT (averaged for tissue or developmental time point)
and expressed as an average (± s.e.m). PCR products from
the SAGE analysis were separated by agarose gel electro-
phoresis and stained with ethidium bromide (0.1 ug/ml).
Tissue-specific expression for the in situ hybridization was
performed on ovarian sections obtained from normal, 6–
8 week old mice. Ovaries were fixed (4% paraformalde-
hyde, PBS, pH 7.4), and processed for paraffin sections (5
µm) which were then re-hydrated stepwise through alco-
hol washes (100%, 70%, 50%, 30%) and distilled water
prior to PBS. Sections were hybridized with sense or anti-
sense probes (200 ng/ml) (see Additional file 4) labeled
with digoxigenin (DIG) according to the manufacturer's
instructions (GenPoint, Dako, Carpenteria, CA) except for
the use of rabbit anti-DIG-HRP antibodies (1:200, Dako,
Carpenteria, CA). Sections were then counter-stained with
hematoxylin and de-hydrated stepwise in ethanol (30%,
50%, 70%, 100%) prior to permount mounting (Fisher
Scientific, Fair Lawn, NJ). Images were acquired with an
Axioplan microscope equipped with a CCD camera using
AxioVision software (Carl Zeiss, Gottingen, Germany).
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